AKAP8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.242400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.771800E-01
Normal-vs-Stage2
5.334400E-01
Normal-vs-Stage3
2.800200E-01
Normal-vs-Stage4
7.081400E-01
Stage1-vs-Stage2
8.154400E-01
Stage1-vs-Stage3
2.682000E-01
Stage1-vs-Stage4
4.614000E-01
Stage2-vs-Stage3
2.477800E-01
Stage2-vs-Stage4
4.203200E-01
Stage3-vs-Stage4
1.679400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.337600E-01
Normal-vs-AfricanAmerican
2.447800E-01
Normal-vs-Asian
5.234400E-01
Caucasian-vs-AfricanAmerican
5.228400E-01
Caucasian-vs-Asian
8.781000E-01
AfricanAmerican-vs-Asian
6.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.316000E-01
Normal-vs-Female
5.184400E-01
Male-vs-Female
8.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.872400E-01
Normal-vs-Age(41-60Yrs)
5.647800E-01
Normal-vs-Age(61-80Yrs)
5.066600E-01
Normal-vs-Age(81-100Yrs)
5.292000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.262800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.852400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.876200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.027400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.857000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.662800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.921400E-01
Normal-vs-Daily Drinker
4.864800E-01
Normal-vs-Weekly Drinker
3.444600E-01
Normal-vs-Occasional Drinker
5.978400E-01
Normal-vs-Social Drinker
4.850800E-01
Non Drinker-vs-Daily Drinker
9.534800E-01
Non Drinker-vs-Weekly Drinker
3.712400E-01
Non Drinker-vs-Occasional Drinker
3.696800E-01
Non Drinker-vs-Social Drinker
9.441400E-01
Daily Drinker-vs-Weekly Drinker
3.336200E-01
Daily Drinker-vs-Occasional Drinker
3.299200E-01
Daily Drinker-vs-Social Drinker
9.858200E-01
Weekly Drinker-vs-Occasional Drinker
9.212200E-01
Weekly Drinker-vs-Social Drinker
3.403800E-01
Occasional Drinker-vs-Social Drinker
3.369000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.089770E-01
Normal-vs-Grade 2
2.097100E-03
Normal-vs-Grade 3
1.114490E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.158190E-01
Grade 1-vs-Grade 3
2.449200E-01
Grade 1-vs-Grade 4
1.089770E-01
Grade 2-vs-Grade 3
5.216800E-01
Grade 2-vs-Grade 4
2.097100E-03
Grade 3-vs-Grade 4
1.114490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.665600E-01
Normal-vs-NonDiabetic
5.270000E-01
Diabetic-vs-NonDiabetic
3.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.277000E-01
Normal-vs-NoPancreatitis
5.019200E-01
Pancreatitis-vs-NoPancreatitis
8.321400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.350600E-01
Normal-vs-N1
5.204600E-01
N0-vs-N1
8.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.170200E-01
Normal-vs-TP53-NonMutant
5.780800E-01
TP53-Mutant-vs-TP53-NonMutant
6.319000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
